NYSEIndustrialsBuilding Products & EquipmentSnapshot 2026-07-23
Reading ASPN? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment is characterized as a turnaround, as ASPN is currently loss-making and struggling with weak financial performance. The thesis is in a cautious state, reflecting recent earnings misses and a need for improvement in revenue and profitability.
The market appears to have a low expectations gap, indicating that ASPN's current valuation is somewhat justified given its recent performance. There is a slight premium compared to peers, suggesting that investors are aware of the risks involved.
Management is focused on restarting its manufacturing facility and maintaining disciplined capital expenditures. However, the trajectory for revenue and profitability remains mixed, with recent declines and a high probability of missing future earnings estimates.
The future of ASPN hinges on the performance of sector bellwethers like TT, JCI, and CARR. Positive earnings from these companies could provide a lift, while negative guidance could further pressure ASPN's performance.
ASPN's outlook is uncertain, with significant challenges ahead and a need for improved execution. Not investment advice.
The most important moves since the prior daily snapshot.
Company momentum rose by 25.0 points (from -65.4 to -40.4).
Signal changed from 'cautious' to 'mixed'.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Hitting this target would show recovery from the big revenue drop in Q1 2026.
Confirms:Q2 2026 revenue reported at or above $40 million.
Disproves:Q2 2026 revenue falls below $40 million.
Why it matters: Lower capital spending shows Aspen is focused on cost control. It can improve cash flow.
Confirms:Capital spending is below $10 million for the year.
Disproves:Capital spending is above $10 million for the year.
Why it matters: If the industrial sector's revenue growth picks up, it could help Aspen Aerogels. The company needs a better market environment.
Confirms:Sector revenue growth exceeds 5% year over year.
Disproves:Sector revenue growth stays below 5% year over year.
